Ambu A/S (AMBBY)
16.12
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
Ambu Market Cap: 4.293B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 10, 2024 | 4.293B |
| May 09, 2024 | 4.293B |
| May 08, 2024 | 4.293B |
| May 07, 2024 | 4.293B |
| May 06, 2024 | 4.293B |
| May 03, 2024 | 4.293B |
| May 02, 2024 | 4.293B |
| May 01, 2024 | 4.293B |
| April 30, 2024 | 4.293B |
| April 29, 2024 | 4.282B |
| April 26, 2024 | 4.282B |
| April 25, 2024 | 4.220B |
| April 24, 2024 | 4.220B |
| April 23, 2024 | 4.220B |
| April 22, 2024 | 4.220B |
| April 19, 2024 | 4.239B |
| April 18, 2024 | 4.239B |
| April 17, 2024 | 4.239B |
| April 16, 2024 | 4.239B |
| April 15, 2024 | 4.239B |
| April 12, 2024 | 4.239B |
| April 11, 2024 | 4.503B |
| April 10, 2024 | 4.530B |
| April 09, 2024 | 4.440B |
| April 08, 2024 | 4.440B |
| Date | Value |
|---|---|
| April 05, 2024 | 4.440B |
| April 04, 2024 | 4.440B |
| April 03, 2024 | 4.440B |
| April 02, 2024 | 4.440B |
| April 01, 2024 | 4.440B |
| March 28, 2024 | 4.440B |
| March 27, 2024 | 4.440B |
| March 26, 2024 | 4.440B |
| March 25, 2024 | 4.440B |
| March 22, 2024 | 4.440B |
| March 21, 2024 | 4.440B |
| March 20, 2024 | 4.440B |
| March 19, 2024 | 4.569B |
| March 18, 2024 | 4.569B |
| March 15, 2024 | 4.655B |
| March 14, 2024 | 4.655B |
| March 13, 2024 | 4.655B |
| March 12, 2024 | 4.655B |
| March 11, 2024 | 4.655B |
| March 08, 2024 | 4.655B |
| March 07, 2024 | 4.655B |
| March 06, 2024 | 4.572B |
| March 05, 2024 | 4.636B |
| March 04, 2024 | 4.636B |
| March 01, 2024 | 4.636B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.053B
Minimum
Sep 27 2022
14.81B
Maximum
Apr 28 2021
5.611B
Average
4.276B
Median
May 23 2023
Market Cap Benchmarks
| Genmab A/S | 18.63B |
| Ascendis Pharma A/S | 7.556B |
| Galecto Inc | 18.43M |
| Evaxion Biotech AS | 19.40M |
| IO Biotech Inc | 94.21M |
Market Cap Related Metrics
| PE Ratio | 123.29 |
| PS Ratio | 5.937 |
| PEG Ratio | 1.152 |
| Price to Book Value | 5.334 |
| Price to Free Cash Flow | 59.49 |
| Price | 16.12 |
| Earnings Yield | 0.81% |
| PEGY Ratio | 1.152 |
| Operating PE Ratio | 80.74 |
| Normalized PE Ratio | 119.67 |